BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2016

Jun 2, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2016-05-31

Reporting Person: Hutson Nancy J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-31	Common Stock	A	2581	$3.39	Acquired	24443	Direct

Footnotes

F1: Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $8,750.